angiotensin II-induced mitochondrial cAMP formation. Inhibition and knockdown of sAC significantly reduce angiotensin II -induced aldosterone production. These data provide the first evidence for a cell-specific functional role of mitochondrial cAMP.
Introduction
Cyclic AMP and Ca 2+ , the two most common second messengers in eukaryotic cells, control a variety of cellular functions as diverse as secretion, contraction, cell movement and death. These two messengers may act synergistically, as observed e.g. in cardiac myocytes, whereas their action may be antagonistic in other tissues, as in smooth muscle cells (Bolton et al., 1999; Schaub and Kunz, 1986; Sperelakis, 1990) . In aldosterone-producing adrenal glomerulosa cells angiotensin II and extracellular K + concentration control aldosterone secretion via Ca 2+ signaling whereas the action of corticotrophin (ACTH) is mediated by cAMP (Spät and Hunyady, 2004) .
Under acute stimulatory conditions the site of action is, in both cases, the Steroidogenic Acute Regulatory Protein (StAR) that facilitates the cholesterol transport to the cholesterol side chain cleaving enzyme (cytochrome P450 scc ), located on the inner mitochondrial membrane (reviewed in (Hattangady et al., 2011; Spät and Hunyady, 2004) ). Calcium ions exert intramitochondrial action(s) as well. By activating mitochondrial dehydrogenases (McCormack et al., 1990) , elevation of mitochondrial matrix [Ca 2+ ] enhances the formation of reduced pyridine nucleotides in rat (Pralong et al., 1992; Pralong et al., 1994) and human (Rohács et al., 1997; Spät et al., 2012) glomerulosa cells. This effect contributes to the enhancement of aldosterone secretion in cells from both species (Spät et al., 2012; Wiederkehr et al., 2011) .
Although ACTH and angiotensin II act synergistically on aldosterone secretion (Spät and Hunyady, 2004) , several laboratories reported that angiotensin II reduces basal and ACTHinduced cAMP production (Bell et al., 1981; Marie and Jard, 1983; Woodcock and Johnston, 1984; Begeot et al., 1987) (but see (Baukal et al., 1994; Burnay et al., 1998) ). This inhibition has been attributed to the activation of the inhibitory G-protein, G i (Enyedi et al., 1986; Hausdorff et al., 1987; Lu et al., 1996; Maturana et al., 1999; Rocco et al., 1990) . The recent discovery in cell lines and rat cardiac myocytes that agonist -induced mitochondrial Ca 2+ signals can increase the production of cAMP and ATP within the mitochondrial matrix (Di Benedetto et al., 2013) may offer an explanation for this apparent paradox. Indeed an increase of cAMP in a small compartment, e.g. mitochondria (that represent  25 % of the cytoplasmic volume in glomerulosa cells (Nussdorfer, 1980) ), may be masked by the decrease of total intracellular cAMP caused by angiotensin II. Accordingly we decided to investigate whether mitochondrial cAMP, mt-cAMP, is modulated by angiotensin II-induced mitochondrial Ca 2+ increases in adrenocortical cells and, more decisively, if mt-cAMP can influence the secretion of steroid hormones. Here we take advantage of a fluorescent cAMP sensor selectively targeted to the mitochondrial matrix (4mtH30) and show that in an adrenocortical cell line, H295R cells (Bird et al., 1993; Rainey et al., 1994) , not only angiotensin II -induced Ca 2+ release from the endoplasmic reticulum results in a significant increase of mt-cAMP formation, but also that the mt-cAMP increase contributes to hormone production.
Materials and methods

Materials
OPTI-MEM, Lipofectamine 2000, RNAiMax, Fluo-4 AM, Rhod-2 AM, SNARF AM and MitoTracker Deep Red were purchased from Life Technologies (Paisley, UK). siRNA for silencing sAC (MR2, (Di Benedetto et al., 2013) ) and control siRNA (Universal Negative Control, SIC001) were obtained from Sigma-Aldrich (St. Louis, MO, USA). UltroSer G was from Bio Sepra (Cergy-Saint-Christophe, France). Coat-A-Count RIA kit was purchased from Siemens Health Care Diagnostic (Deerfield, IL). S100G cDNA, fused to a mitochondrial targeting sequence and cloned into an adenovirus vector under the control of the tetON promoter (mitoS100G) was prepared by Dr. A. Wiederkehr (Geneva, Switzerland). H30 was from K. Jalink's lab (Ponsioen et al., 2004) , 4mt-H30 and mtAlphi were constructed by the authors (G.D. & T.P.) as described (Cano Abad et al., 2004; Di Benedetto et al., 2013) .
Primary antibodies were purchased as follows: anti-soluble adenylyl cyclase (R21.002) was from CEP Biotech (Tamarac, FL), monoclonal anti--actin (A5316) was from Sigma-Aldrich, anti-COX IV (sc-69359) was from Santa Cruz (Dallas, TX). The secondary antibody (goat antimouse IgG horseradish peroxidase conjugate, R-05071-500) was purchased from Advansta (Menlo Park, CA). Other chemicals were obtained from Sigma-Aldrich.
Cell culture and transfection
H295R cells (CRL-2128, ATCC, Manassas, VA) were cultured in DMEM/Ham's F12 (1:1 v/v) containing 1% ITS + , 2% UltroSer G, 100 U/ml penicillin and 100 µg/ml streptomycin. One day before aldosterone experiments the concentration of Ultroser G was reduced to 0.5 %.
Cells (2.5 -4*10 4 H295R) were plated onto 25-mm diameter circular glass coverslips on day 1. For FRET experiments the cells were transfected on day 2 with 3 g 4mtH30 or 1.6 g H30 DNA (per coverslip) using Lipofectamine 2000 in OPTI-MEM. FRET measurements were performed on day 5 (4mtH30) or day 4 (H30). For silencing sAC, on day 3 the cells were transfected with 100 pmol MR2 siRNA or 100 pmol control RNA using lipofectamin RNAiMax in OPTI-MEM. The experiments were conducted on day 5. In Western blot studies cell lysis was performed 2 days after transfection with control or siRNA. For aldosterone measurements see subsection 2.7.
In order to increase the Ca 2+ buffering capacity in the mitochondrial matrix 3*10 4 cells were plated and infected 1 day later with Ad-mitoS100G (60 IFU/cell) together with 30 IFU/cell of Ad-tetON. Previous immunocytochemical examination using this protocol revealed the expression of S100G in 63% of the cells (Wiederkehr et al., 2011) .
Immunoblotting
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Cell lysis, SDS-PAGE and immunoblotting were performed as described (Fülöp et al., 2011) with the following modifications. Cell lysis was performed with protease-completed RIPA buffer.
PMSF was used at a concentration of 1 mM. 10 % SDS-PAGE was used.
Confocal microscopy
A Zeiss LSM710 confocal laser scanning microscope (operated with ZEN 11.0 software) and a 63*/1.3 oil immersion objective (Plan-Apochromat, Zeiss) were used. Subcellular localisation of the cAMP sensors (H30 or 4mt-H30) was examined in cells preloaded with MitoTracker Deep
Red. Applying multitrack mode the YFP component of the sensor was excited at 514 nm, emitted light was measured between 520 and 595 nm whereas MTDR was excited at 633 nm and monitored at 640-740 nm. The images were deconvoluted using ImageJ 1.6.0.
For monitoring cytosolic Ca 2+ signals the cells were preloaded with Fluo-4, for recording mitochondrial pH changes the cells were transfected with mtAlphi. In both cases the applied excitation wavelength was 488 nm, the emitted light was monitored between 500-550 nm. For monitoring cytosolic pH the cells were preloaded with SNARF AM, the dye was excited at 488 and the intensity of 612-699 nm emitted light was divided with that of the 560-600 nm light.
The optical slices were 4 m in the cytosolic measurements and 1.5 m in the mitochondrial ones, respectively. As exception, H30 localisation examinations 0.8 or 1 µm optical slice was applied. Image acquisition frequency was 0.1 Hz. In all kinetic studies performed with confocal microscopy fluorescence intensity was normalized to the average 60-s intensity measured before stimulation (F o ).
Measurements with fluorescent wide-field microscopy
cAMP level in the mitochondrial matrix and in the cytosol were monitored using 4mt-H30 Rhod-2 excitation wavelength was 550 nm. The emitted light passed through a 570-nm dichroic mirror and was measured with a 610/50 filter. The expressed fluorescence emission values (F) were normalized to the mean F value of the 100-sec period prior to stimulation.
Superfusion
Microscopic experiments were carried at room temperature. Hepes and 2 mM HCO 3  (pH 7.4). The flow rate was ~ 1ml/min. The solutions were applied with a solenoid valve-equipped, gravity-driven superfusion system, terminating at ~2 mm from the selected cells.
Aldosterone production
Cells (150 -300 thousand/well) were plated in a 24-well culture dish (day 1). On day 3 the UltroSer G content of the culture medium was reduced to 0.1 %. On day 4, after a 30-min preincubation in serum-free medium that contained 2-OHE or solvent, the cells were incubated at 37 o for 2 hours in a similar medium, with or without angiotensin II. When the cells were transfected with control or siRNA on day 2, UltroSer G content was reduced on day 4 and final incubation, as detailed above, took place in day 5.
Aldosterone and protein content of the supernatant were determined with Coat-A-Count RIA kit and Bradford assay, respectively.
Statistics
Means + S.E.M. are used. With the exception of cytosolic pH measurements all the experiments were performed on cells derived from at least two different cell passages. For estimating significance of differences, Student's unpaired t-test, sign test, chi-square test or factorial ANOVA was used, as appropriate. Data were analyzed with Statistica 9.
Results
Expression of soluble adenylyl cyclase in H295R cells
A specific antibody against sAC (Zippin et al., 2003) Altogether, these data are compatible with the conclusion that the majority of sAC in H295R cells, similarly to COS-1 cells (Acin-Perez et al., 2009b) is not cytosolic, but it is localized in membrane bound organelles, most likely the mitochondria .
Mitochondrial cAMP as measured with 4mtH30 in H295R cells
The cAMP sensor 4mtH30 consists of 4 copies of human COX VIII targeting sequence fused to the N-terminus of the cAMP sensor H30. The latter contains, between ECFP and EYFP, the whole Epac1 protein, rendered catalytically inactive with two mutations in the Rap1 binding domain and deprived of the membrane-targeting DEP domain (Ponsioen et al., 2004) . Confocal microscopy revealed that in H295R cells, 3 days after transfection, 4mtH30 shows, as previously To test whether intramitochondrial cAMP level can be modulated by activation of matrix sAC, H295R cells transfected with 4mtH30, were superfused with an isosmotic medium containing 50 mM HCO 3 -(as sAC is known to be activated by bicarbonate ions (Buck et al., 1999; Jaiswal and Conti, 2003; Litvin et al., 2003; Steegborn et al., 2005b) ). An increase in the ΔR/R 0 was observed in 75 % of the examined 20 cells ( Fig. 2A) . Noteworthy, in parallel, the measurement of matrix pH with mtAlphi (Cano Abad et al., 2004 ) revealed a net alkalinisation upon HCO 3 -addition (n=20, Fig. 2C ). Given that pH alkalinization results in an increase of YFP fluorescence (Di Benedetto et al., 2013) , the total rise of mt-cAMP may be underestimated.
The data presented in the section showed that the cAMP sensor 4mtH30 was appropriately targeted to the mitochondrial matrix (as previously described (Di Benedetto et al., 2013) ) and responded in the expected way to bicarbonate, applied as positive control.
Effect of angiotensin II on mitochondrial cAMP formation
In preliminary experiments we examined the effect of 1 and 10 nM angiotensin II on the level of mt-cAMP. The effect of 1 nM was recorded in 133 cells. A cell was regarded responsive in terms of cAMP response if the integrated R/R 0 value within at least a 100-sec period during the 5-min post-stimulation period was significantly greater (p < 0.05) than that within a similar period preceding the stimulation. Elevation of mt-cAMP was observed in 40 %, whereas a small decrease of the mt-cAMP signal was detected in 6 % of cases (p < 0.01).
In the next series of experiments we studied the effects of 10 nM angiotensin II. Fig. 3C ) and the not responding were the remaining 19 % of the cells (Fig. 3B) . Given that the percentage of responding cells in the 10 nM angiotensin II group was significantly higher than in the 1 nM group (p = 0.0001), in subsequent experiments we focused on the effects of 10 nM angiotensin II.
Considering the variability of cAMP rises in different cells and different preparations both in terms of amplitude and kinetics, a significant parameter to compare different conditions appeared to be the percentage of responsive cells. This parameter was, unless otherwise indicated, used in evaluating the following experiments. In order to inhibit sAC cells stimulated with 10 nM angiotensin II, were exposed to the sAC inhibitor 2-OHE (20 M) (Steegborn et al., 2005a) . The inhibitor was present also during a 30-min preincubation. Supplementary Fig. 3 demonstrates that the drug did not modify either the cytosolic or mitochondrial Ca 2+ response to angiotensin II; however, at the same dose, it reduced the percentage of cells showing a mt-cAMP increase to angiotensin II by 34 % (p = 0.0135, Fig. 4A ). The specificity of the inhibitor was confirmed by transfecting the cells 2 days earlier with MR2, a specific siRNA for the sAC gene. In this case the percentage of responding cells decreased by 67 % (p = 0.006, Fig. 4B ). Di Benedetto et al. (2013) showed that a generic inhibitor of phosphodiesterases PDE, such as IBMX, or a PDE2A specific blocker, increase mt-cAMP level in response to stimulation. We thus examined the effect of the PDE2A inhibitor EHNA (erythro-9-(2-hydroxyl-3-nonyl)adenine (Acin-Perez et al., 2011)) on angiotensin II -induced changes in mt-cAMP. EHNA also added to the preincubating medium, evoked no significant change in the percentage of responsive cells, but the peak amplitude of the response was significantly higher in the presence of 10 µM EHNA (p = 0.007, Fig. 4D ).
In order to confirm that angiotensin II -induced mt-cAMP response was induced by increased mitochondrial [Ca 2+ ], the peak increases in matrix Ca 2+ were attenuated with heterologously expressed mitoS100G, a mitochondria-targeted Ca 2+ binding protein under the control of doxycycline (DOX) -inducible tetOn promoter (Wiederkehr et al., 2011) . We previously demonstrated that expression of mitoS100G results in a significant reduction in the amplitude of the mitochondrial Ca 2+ increases. In DOX-negative control cells 9 out of 14 cells showed an angiotensin II -induced mt-cAMP increase, whereas only 3 out of 12 cells showed a similar response after DOX-dependent infection. The difference between the two groups was significant (p = 0.045, Fig. 4C ).
The data in this section thus show that the mitochondrial sAC can be activated by angiotensin II in a concentration-dependent way. Pharmacological inhibition and silencing of sAC, as well as Ca 2+ buffering in the mitochondrial matrix, reduce the effect of angiotensin II whereas inhibition of the mitochondrial cAMP phosphodiesterase enhances the angiotensin-induced rise of mtcAMP.
Role of mitochondrial cAMP in the control of aldosterone production
We next investigated whether mt-cAMP plays any role in steroid hormone secretion, the specific function of adrenocortical cells. H295R cells were exposed for 2 hours to angiotensin II, applied at maximal (1 nM) or supramaximal concentration (10 nM) and their aldosterone production was measured. Angiotensin II evoked a mean 2.7 fold increase in aldosterone secretion whereas the increase in 2-OHE treated cells was reduced to 1.5 fold on average (Fig.   5A ). Statistical analysis after pooling the 1 and 10 nM data showed that the effect of 2-OHE was highly significant (p = 1 x 10 -6 ) and, more importantly, the negative interaction of the agonist and the enzyme inhibitor was also highly significant (p = 1 x 10 -6 ).
The observation obtained with pharmacological inhibition of sAC has been confirmed by transfection with siRNA. The 2-hour hormone production was examined 3 days after transfection with 0. As shown in Fig. 5B aldosterone secretion in siRNA-transfected cells was significantly smaller than in control RNA-transfected cells (p = 0.002) and, more importantly, the extent of stimulation was reduced from an average of 1.61 to 1.47, reflecting a significant negative interaction of gene silencing with the agonist (p = 0.041).
sAc is localized both in the cytosol (Braun and Dods, 1975; Jaiswal and Conti, 2001 ) and in the mitochondrial matrix (Acin-Perez et al., 2009a). The question then arises as to whether the effects of sAC inhibition on aldosterone production depends on mt-sAC or cytosolic sAC or both.
In order to distinguish among these possibilities cells were transfected with H30, the cytosolic version of the cAMP sensor. The probe, as expected, was selectively localized in the cytosol and excluded from mitochondria ( Fig. 6A and B) . 10 nM angiotensin II induced a clear cytosolic cAMP rise in 16 out of 22 cells (Fig. 6C) in controls, the average ΔR/R o of a 100-sec stimulation period in the responding control cells showed a 3.93 + 0.45 % increase. The sAC inhibitor 2-OHE failed to influence this cytosolic cAMP response: 75 % of 2-OHE-treated cells responded to angiotensin with cAMP signal, the average ΔR/R o showed a 3.85 + 0.35 % increase (Fig. 6D ).
This observation demonstrates that angiotensin II is capable of increasing cytosolic cAMP level by activating a 2-OHE insensitive AC. In addition, superfusion with 50 mM bicarbonate (that induces an increase in mt-cAMP) is associated with a drop in ΔR/R o in the cytosol in 75 % of the cells (n = 16, Fig. 6E ). This drop is probably only apparent as bicarbonate induces an alkalinization of cytosolic pH, similar in amplitude to that caused in the mitochondrial matrix (not shown). We thus conclude that in H295R cells: i) the activity of sAC in the cytosol is negligible and ii) inhibition of angiotensin II-induced aldosterone production by 2-OHE depends on its inhibition of mitochondrial sAC.
Summarizing the data in this section, basal and angiotensin II-stimulated aldosterone secretion was reduced by inhibiting or silencing sAC. The activity of sAC in the cytosol is negligible, but the cytosolic Ca 2+ increase elicited by angiotensin II can activate transmembrane adenylyl cyclase(s).
Discussion
The recent discovery of the existence of an autonomous intramitochondrial cAMP signaling machinery (composed by a sAC isoform and a cAMP degrading mechanism sensitive to both IBMX and EHNA, a PDE2 specific inhibitor (Acin-Perez et al., 2009b)) has been followed by the direct demonstration that in HeLa and CHO cells as well as in rat cardiomyocytes a rise in cAMP can be triggered by an increase in HCO 3 -and Ca 2+ in the matrix, acting synergically (Di Benedetto et al., 2013) . Intramitochondrial cAMP rise is paralleled by a significant increase of the matrix level of ATP. On the contrary, no consensus exists as to the target(s) of cAMP in the mitochondrial matrix (see for example (Acin-Perez et al., 2009b; Di Benedetto et al., 2013; Lefkimmiatis et al., 2013) ). Moreover, and most importantly, the possible functional effects of this cAMP increase are still largely unexplored.
In the present paper we have investigated whether the matrix cAMP signaling toolkit is expressed also in other differentiated cell types and whether functions other than ATP production can be modulated by the cAMP concentration in the matrix. To this end we used an adrenocortical cell line, H295R cells, a model system widely employed to investigate the function of glomerulosa cell, especially the agonist dependent production of aldosterone (Bird et al., 1993; Rainey et al., 1994) . For estimating mt-cAMP formation we employed the FRET-based sensor 4mtH30 (Di Benedetto et al., 2013) . This sensor, as other probes of the same family, undergoes a change (reduction) of FRET upon increases in the local cAMP level. However other factors, e.g., differential photobleaching of CFP and YFP fluorescence or pH changes may lead to apparent, artifactual, changes in mt-cAMP. These problems were directly addressed in the present experiments and in the study of Di Benedetto et al. (2013) . In particular, as far as photobleaching is concerned, superfusion with control medium for 450 s (the maximal duration of the treatments with drugs or agonists) failed to exert any significant influence on the FRET signal. As to pH effects, neither 2-OHE or EHNA cause any change of matrix pH (Di Benedetto et al., 2013) .
Last, but not least, all the treatments used (sAC inhibitor 2-OHE, siRNA against sAC or the phosphodiesterase inhibitor EHNA) modified mt-cAMP in the expected direction, giving concordant results. More specifically, we here demonstrate that: i) angiotensin II, an agonist known to induce (often oscillatory) increases in cytosolic and mitochondrial Ca 2+ (Brandenburger et al., 1996; Lalevee et al., 2003; Spät and Hunyady, 2004; Spät and Pitter, 2004) , as well as reduction in pyridine nucleotides (Pralong et al., 1992; Pralong et al., 1994; Rohács et al., 1997) , also causes a dose dependent rise in mt-cAMP; ii) the effects of angiotensin II on mt-cAMP are reduced by buffering matrix Ca 2+ increases caused by the expression of mitoS100G (Wiederkehr et al., 2011) , by siRNA reduction in sAC expression or by the sAC inhibitor 2-OHE and are augmented by the PDE2A inhibitor EHNA; iii) a clear increase in mt-cAMP is also caused by the well known sAC activator, bicarbonate (Buck et al., 1999; Jaiswal and Conti, 2003; Litvin et al., 2003; Steegborn et al., 2005b) . Three lines of evidence support the conclusion that sAC is primarily localized in the mitochondria: i) the majority of the protein band (molecular weight 50 kDa), revealed in lysates of H295R cells by immunoblotting with anti-sAC antibodies and corresponding to the truncated, fully active form of sAC (Buck et al., 1999) , remained in the pellet after plasma membrane permeabilization with digitonin; ii) the mitochondrial cAMP sensor 4mtH30 and the cytosolic sensor H30 responded with opposite signals to bicarbonate addition, i.e. a rise with 4mtH30 and a small drop with H30, though bicarbonate caused an alkalinization in both compartments; iii) the sAC inhibitor 2-OHE added together with angiotensin II, attenuated the mt-cAMP signal, but had no effect on the cytosolic cAMP rise caused by the stimulus.
The final key question concerns the functional significance of the mt-cAMP formation. In order to address this point we investigated the effect of manipulating mt-cAMP on the primary biological function of adrenocortical cells, namely hormone production. The stimulation of aldosterone production by the cAMP rise induced by ACTH addition and the role of angiotensin II (or K + ) dependent rise in cytosolic Ca 2+ on hormone production (and the potentiation of cytosolic Ca 2+ -evoked aldosterone production (Wiederkehr et al., 2011) by mitochondrial Ca 2+ rises) are firmly established facts. On the contrary, the crosstalk between the Ca 2+ and cAMP signaling systems has been thoroughly investigated in the past, but conflicting results have been reported. The Tait group showed a K + -evoked increase in cAMP formation in rat glomerulosa cells (Hyatt et al., 1986) . Several years later, the Ca 2+ -activatable isoform 1 of adenylyl cyclase (AC1) was shown to be expressed in human glomerulosa and fasciculata cells (Cote et al., 2001) whereas another isoform (AC3), possibly also activated by Ca
2+
, was found in human (Cote et al., 2001 ), rat (Nishimoto et al., 2013) and bovine (Burnay et al., 1998) glomerulosa cells. On the contrary, a reduced cAMP formation was reported in angiotensin II -stimulated rat glomerulosa (Bell et al., 1981; Woodcock and Johnston, 1984) or bovine adrenocortical cells (Begeot et al., 1988; Marie and Jard, 1983 -inhibited isoforms (AC5 and AC6, (human: (Cote et al., 2001) , rat: (Shen et al., 1997) ) is a species (or cell) specific feature and may account for the different results obtained in different models. Despite these contradictions on the relationships between angiotensin II stimulation and cAMP levels, a consensus exists on the synergic actions of cytosolic cAMP produced by ACTH and Ca 2+ rises on aldosterone production (Spät and Hunyady, 2004 suggests that, similarly to what occurring for the cysosolic compartment, the mt-cAMP rise synergizes with intramitochondrial Ca 2+ in regulating aldosterone biosynthesis. The specific molecular target of mt-cAMP, however, remains to be established (Lefkimmiatis et al., 2013) .
Summarizing the present observations, in addition to a possible activation of a transmembrane AC by the cytosolic Ca 2+ signal, also a mitochondrial AC, the soluble sAC, is activated by mitochondrial Ca 2+ increases. Activation of sAC and thus of mt-cAMP, enhances the Ca 2+ -induced production of aldosterone, a hormone controlling not only salt-water balance, but also playing a significant role in the control of blood pressure and in the progress of various cardiovascular, renal and inflammatory diseases (Andersen, 2013; Briet and Schiffrin, 2010; Gomez-Sanchez, 2014; Tomaschitz et al., 2010) . These data provide the first evidence that cAMP rise in mitochondria has not only a general bioenergetics function (stimulation of ATP production 
